Results 21 to 30 of about 57 (46)

Changes of serum high mobility group box 1 and soluble triggering receptor expressed on myeloid cells-1 in patients with multiple injuries and their prognostic significance [PDF]

open access: yes
Objective·To detect the serum levels of high mobility group box 1 (HMGB1) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in patients with multiple injuries at different time points, and to analyze their correlation with disease ...
DU Chuanchong   +6 more
core   +1 more source

新诊断2型糖尿病患者血清炎症因子及外周血单个核细胞中核因子κB活性变化 [PDF]

open access: yes, 2006
【目的】探讨新诊断2型糖尿病患者血清炎症因子超敏-C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)、白介素-6(IL-6)水平及外周血单个核细胞(PMNC)中NF-κB的活性变化。【方法】选择健康成人66例,新诊断2型糖尿病患者92例,分为正常对照组和2型糖尿病组,分析比较两组血清炎症因子及PMNC中NF-κB活性水平。血清hs-CRP、TNF-α、IL-6采用酶联免疫吸附法测定。免疫印迹分析检测PMNC中核因子KBp65(Set^536)的磷酸化水平,β-actin作为内参。【结果 ...
严励   +6 more
core  

硫辛酸胶囊超说明书用药调查分析 [PDF]

open access: yes, 2017
目的了解和分析门诊患者硫辛酸胶囊超说明书使用情况,促进临床合理用药。方法利用厦门大学附属第一医院审方决策系统筛选出门诊2017年5—7月使用硫辛酸胶囊的医嘱处方691份,根据硫辛酸胶囊的药品说明书,从适应证、用法用量、用药人群等方面对每个医嘱逐项判断其是否与药品说明书相符,若有不相符则判断其存在超说明书用药,分析超说明书用药类型及发生率、适应证用药及构成比。结果从本院审方决策系统534077份处方中筛选出使用硫辛酸胶囊的处方691份,占0.13%,其中超硫辛酸胶囊说明书用药处方612份,发生率为88 ...
李灵琦
core   +1 more source

一种定量检测人血清高敏C反应蛋白的化学发光免疫方法 [PDF]

open access: yes, 2010
旨在建立一种可定量检测人血清高敏CRP的化学发光检测方法(High-sensitivity C-reactive protein quantifiable chemiluminescent immunoassay,hs-CRP CLIA)。首先利用亲和层析和离子交换层析技术从肝硬化病人腹水中纯化出高纯度的天然CRP作为免疫原制备了22株CRP单克隆抗体(单抗),其中13株单抗在磷酸胆碱配体捕获ELISA中呈阳性,然后利用方正滴定法筛选出单抗10C5和10C11建立了hs-CRP CLIA ...
刘平果   +8 more
core  

芪参益气滴丸对ApoE基因敲除小鼠动脉粥样硬化中调节性T细胞的影响 [PDF]

open access: yes, 2018
目的:研究芪参益气滴丸对动脉粥样硬化中调节性T细胞的影响。方法:采用6周龄雄性C57BL/6J小鼠和Apo E基因敲除小鼠,分为正常组、模型组、芪参低剂量组、芪参高剂量组,每组6只。除正常组外,其他3组小鼠均给予高脂饲料喂养,药物组还给予高、低剂量的芪参益气滴丸,8周后评价内脏指数、动脉粥样硬化病变、调节性T细胞情况。结果:与模型组比较,芪参高剂量组可显著降低肝指数 ...
卢大为   +9 more
core  

Effect of different antibiotics combined with tigecycline in patients with multidrug-resistant Acinetobacter baumannii-related ventilator-associated pneumonia: A comparative study [PDF]

open access: yes
Objective To investigate the effect of different antibacterial agents combined with tigecycline in patients with multidrug-resistant Acinetobacter baumannii (MDRAB)-related ventilator-associated pneumonia (VAP), and to provide options for better ...
SHI Xinyan, SHANG Ning, WANG Hong, YANG Tingting, ZHAO Chunling, QI Weiwei, LIU Wei
core   +1 more source

炎症、毒邪与动脉粥样硬化 [PDF]

open access: yes, 2009
炎症反应贯穿动脉粥样硬化(atherosclerosis,AS)发生、发展及易损斑块形成和破裂的全过程。中医毒邪致病理论,即外来之毒与内生之毒相互作用产生的痰毒、瘀毒、热毒在粥样斑块的形成中起重要作用,说明炎症反应贯穿"痰瘀热毒"产生的全过程,痰毒、瘀毒和热毒作为病邪又可诱发机体炎症反应,这样反复循环,可致粥样斑块形成和不断增大。因此,AS发生 ...
吕崇山, 董欢
core  

针刺大都穴治疗中风偏瘫疗效观察 [PDF]

open access: yes, 2016
目的:观察针刺大都穴对中风偏瘫下肢的影响及临床疗效。方法:将72例患者随机分成两组:治疗组37例采用基础穴位配合大都穴治疗;对照组35例采用基础穴位结合神经肌肉电刺激仪治疗,治疗1个月后比较两组的临床疗效。结果:通过下肢Fugl-Meyer量表评分比较,治疗组均优于对照组 ...
吴文裕, 吴明霞, 林振原
core  

不同剂量氯吡格雷对急性脑梗死患者神经功能及预后不良事件的影响 [PDF]

open access: yes, 2019
目的探讨不同剂量氯吡格雷治疗急性脑梗死(CI)患者的效果及安全性。方法选取86例急性CI住院患者,采用简单随机分组法分为大剂量组(n=43)与小剂量组(n=43)。在常规对症治疗基础上,大剂量组给予氯吡格雷150 mg,小剂量组给予氯吡格雷常规剂量75 mg,均持续治疗3个月。比较2组治疗前后血小板计数、血小板聚集率、美国国立卫生研究院卒中量表(NIHSS)评分、预后不良事件发生情况。结果大剂量组治疗后血小板计数、血小板聚集率、NIHSS评分均较治疗前显著下降(P 0.05)。大剂量组神经功能恶化率4.
张旭, 蔡海明, 郑燕红
core  

Oral mucosal manifestations of Sweet’s syndrome: a case report and literature review [PDF]

open access: yes
Objective To explore the oral mucosal manifestations of Sweet’s syndrome and provide a reference for its early detection and correct diagnosis. Methods The oral mucosal manifestations of a 60-year-old female patient with Sweet’s syndrome are described in
NIU Yufen, YANG Fang, DONG Lei, FAN Jicai, ZHANG Chunyan
core   +1 more source

Home - About - Disclaimer - Privacy